Scientists dig into data of 370 kids to crack brain tumor resistance

NCT ID NCT05151718

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 08, 2026 · Last updated Jun 08, 2026

Summary

This study looks back at data from 370 children and teens treated for ependymoma, a common brain tumor. Researchers want to understand why half of these tumors come back after surgery and radiation. They will use advanced imaging, genetics, and artificial intelligence to find patterns that predict relapse. The goal is to design better, more personalized radiation treatments for the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Institut Claudius Regaud
RECRUITING

Toulouse, 31059, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

EPENDYMOMA OF BRAIN PEDIATRIC SOLID TUMOR

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

PEDIATRIC EPENDYMOMA